New Key Statistics Module, Z-Score and F-Score
AMEX:IBIO Key Ratios
| Market Cap $ M | 24.30 |
| Enterprise Value $ M | 14.65 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.08 |
| Price/Sales | 43.04 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -10.97 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | 33.30 |
| 5-y EBITDA Growth Rate % | 51.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.94 |
| EV-to-EBITDA | -1.03 |
| PEG | -- |
| Shares Outstanding M | 9.14 |
| Net Margin (%) | -11,069.78 |
| Operating Margin % | -7,392.89 |
| Pre-tax Margin (%) | -6,863.56 |
| Quick Ratio | 4.08 |
| Current Ratio | 4.08 |
| ROA % (ttm) | -64.93 |
| ROE % (ttm) | -148.30 |
| ROIC % (ttm) | -55.59 |
| Dividend Yield % | -- |
| Altman Z-Score | -14.57 |
IBIO Number of Guru Trades
IBIO Volume of Guru Trades
Gurus Latest Trades with AMEX:IBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:IBIO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
iBio Inc Insider Transactions
No Available Data
News about AMEX:IBIO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers